Thu.May 26, 2022

article thumbnail

Biotech founder arrested in US amid murder-for-hire investigation

pharmaphorum

The co-founder of Los Angeles biotech Enochian Biosciences has been arrested in connection with a federal investigation into the murder of a Vermont man in 2018. Serhat Gümrükcü (39) has been charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire, along with alleged co-conspirator Berk Eratay (35) of Las Vegas.

article thumbnail

Can pharmacy techs work at more than one pharmacy?

SingleCare

With the cost of living on the rise, having a steady income is crucial. But sometimes even regular employment doesn’t cover all of the outgoing expenses you might have—which are often multiplied if you’re living in a city or expensive area. Just like many other professions, pharmacy technicians might be feeling the financial squeeze right now.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cumulus puts its digital biomarkers for CNS diseases to the test

pharmaphorum

Cumulus Neuroscience has started a pair of clinical trials to gauge the value of a panel of physiological and digital biomarkers in tracking the course of neurodegenerative diseases, including Alzheimer’s. The hope is that the toolkit will improve on current measurement tools for dementia and other neurological conditions that have serious limitations, according to the Northern Ireland company’s chief scientific officer Brian Murphy.

FDA 59
article thumbnail

Events and training for pharmaceutical microbiologists 2022

Pharmig

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post Events and training for pharmaceutical microbiologists 2022 appeared first on Pharmig.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Mechanisms of Psychedelic Tryptamines: 5-MeO-DMT vs. Classics

The Spirit Pharmacist

In this video blog I wanted to address the pharmacologic mechanisms of 5-MeO-DMT in reference to classic psychedelic tryptamines like LSD, psilocybin, and DMT. Psychedelic Tryptamines are Serotonin 2A Stimulating Substances. A common feature of all psychedelic tryptamines is their ability to bind and stimulate serotonin 2A (5HT2A) receptors. Experiments that pre-treat persons or rodents with 5HT2A receptor blocking antipsychotic medications have all demonstrated that psychedelic effects are grea

article thumbnail

Leveraging KOL insights to succeed in a data-driven world

pharmaphorum

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in a specific therapeutic area, notable experience working in a particular field, or their connections with researchers, decision-makers, and patients. In a traditional setting, where face-to-face interactions are prioritised, identifying KOLs is relatively straightforward.

More Trending

article thumbnail

How automatization keeps drug safety in war-torn Ukraine

pharmaphorum

Ukrainian pharmaceutical companies are struggling to perform their duties in pharmacovigilance as Russia launched a wide-scale war in Ukraine. Automatization may be a solution. Russia’s full-scale invasion of Ukraine has already affected the global pharmaceutical industry a lot. Some companies have terminated their contracts with Russia, while some manufacturers have lost their revenue partially. .

article thumbnail

eBook: Contract manufacturing trends (Spring 2022)

Pharma Manufacturing

New, complex therapies coming through the pharma pipelines are putting immense pressure on supply chains and manufacturing capacity, challenging traditional scale-up and manufacturing processes at the same time — and CDMOs have stepped up into the thick of it all.

40
article thumbnail

Lilly sets aside $2.1bn for domestic investments

pharmaphorum

Eli Lilly’s home state of Indiana is set to benefit from a massive $2.1 billion investment by the pharma group, earmarked for two brand new manufacturing facilities. The two plants will both be located at the LEAP Lebanon Innovation and Research District in Boone County, a few miles to the north west of Lilly’s headquarters in the Hoosier state capital Indianapolis.

FDA 52
article thumbnail

eBook: Predictions and trends 2022

Pharma Manufacturing

While change does not always happen quickly in the pharma industry, the ongoing global pandemic has quickened the pace of emerging trends.

45
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA clears new first-line use for Servier’s Tibsovo in AML

pharmaphorum

Servier is on course to get a return on its $1.8 billion takeover of Agios Pharma’s oncology business after getting a key FDA approval for Tibsovo, the main asset in the deal. The US regulator has approved Tibsovo (ivosidenib) in combination with Bristol-Myers Squibb’s chemotherapy Vidaza (azacitidine) as a first-line therapy for IDH1-mutated acute myeloid leukaemia (AML), expanding the eligible patient population for the drug.

FDA 52
article thumbnail

EC approves Janssen T-cell therapy for multiple myeloma treatment

Pharma Times

Approval provides another step forward in transforming multiple myeloma outcomes and eliminating the disease

37
article thumbnail

Why are clinical trials struggling with diversity?

pharmaphorum

In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative. In recent years this has seen diversity, equity, and inclusion (DEI) become a big focus for industries to get right. Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening.

Packaging 142
article thumbnail

NICE recommendation for Sanofi and Regeneron’s CSCC treatment

Pharma Times

Libtayo has been approved for adults when curative surgery or radiation is not appropriate

40
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.